184 related articles for article (PubMed ID: 31432738)
1. Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.
Lu Z; Li B; Gu C
J Int Med Res; 2019 Oct; 47(10):4895-4903. PubMed ID: 31432738
[TBL] [Abstract][Full Text] [Related]
2. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
3. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
4. Management of borderline ovarian tumours.
Gershenson DM
Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
Chen R; Zhu T; Yu H; Zhu J; Lu X
Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
[TBL] [Abstract][Full Text] [Related]
7. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
8. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.
Gungorduk K; Asicioglu O; Braicu EI; Almuheimid J; Gokulu SG; Cetinkaya N; Gungor T; Pakay G; Telli EU; Cuylan ZF; Toptas T; Bilgi A; Ozyurt R; Agacayak E; Ozdemir A; Yildirim N; Taskin S; Oge T; Erol O; Akman L; Turan A; Icen MS; Senol T; Ovali OI; Yucesoy B; Gungorduk O; Temizkan O; Sanci M; Simsek T; Meydanli MM; Harma M; Yasar L; Uysal AD; Karateke A; Ortac F; Ozalp SS; Sehouli J; Muallem MZ
Anticancer Res; 2017 Oct; 37(10):5609-5616. PubMed ID: 28982877
[TBL] [Abstract][Full Text] [Related]
10. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
[TBL] [Abstract][Full Text] [Related]
11. Unilateral cystectomy and serous histology are associated with relapse in borderline ovarian tumor patients with fertility-sparing surgery: a systematic review and meta-analysis.
Li N; Ming X; Li Z
Arch Gynecol Obstet; 2020 Nov; 302(5):1063-1074. PubMed ID: 32748055
[TBL] [Abstract][Full Text] [Related]
12. Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population.
Nasioudis D; Alevizakos M; Holcomb K; Witkin SS
Maturitas; 2017 Feb; 96():45-50. PubMed ID: 28041594
[TBL] [Abstract][Full Text] [Related]
13. Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.
Falcone F; Breda E; Ferrandina G; Malzoni M; Perrone AM; Cormio G; Di Donato V; Frigerio L; Mangili G; Raspagliesi F; Festi A; Scibilia G; Biglia N; Sorio R; Vizza E; Losito NS; Greggi S
Gynecol Oncol; 2021 Jun; 161(3):825-831. PubMed ID: 33781554
[TBL] [Abstract][Full Text] [Related]
14. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
[TBL] [Abstract][Full Text] [Related]
15. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
[TBL] [Abstract][Full Text] [Related]
16. Current limits of conservative treatment in ovarian cancer.
Gracia M; Alonso-Espías M; Zapardiel I
Curr Opin Oncol; 2023 Sep; 35(5):389-393. PubMed ID: 37498109
[TBL] [Abstract][Full Text] [Related]
17. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.
Uzan C; Muller E; Kane A; Gouy S; Bendifallah S; Fauvet R; Darai E; Morice P
Hum Reprod; 2013 Dec; 28(12):3222-6. PubMed ID: 24067602
[TBL] [Abstract][Full Text] [Related]
18. The feasibility of fertility-sparing surgery in treating advanced-stage borderline ovarian tumors: A meta-analysis.
Huang Y; Zhang W; Wang Y
Taiwan J Obstet Gynecol; 2016 Jun; 55(3):319-25. PubMed ID: 27343308
[TBL] [Abstract][Full Text] [Related]
19. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]